US Stock MarketDetailed Quotes
LFST LifeStance Health
- 7.680
- +0.550+7.71%
Close Nov 7 16:00 ET
- 7.680
- 0.0000.00%
Post 17:03 ET
2.94BMarket Cap-30720P/E (TTM)
8.610High7.550Low5.78MVolume7.750Open7.130Pre Close45.96MTurnover4.45%Turnover RatioLossP/E (Static)382.64MShares9.20052wk High2.04P/B997.09MFloat Cap4.64052wk Low--Dividend TTM129.83MShs Float29.811Historical High--Div YieldTTM14.87%Amplitude4.220Historical Low7.953Avg Price1Lot Size
LifeStance Health Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 10,252.07%44.06M | -176.78%-21.84M | -131.98%-16.88M | -53.24%16.8M | -542.50%-25.36M | -105.54%-434K | -338.51%-7.89M | 460.39%52.79M | 17.24%35.92M | 140.33%5.73M |
| Net income from continuing operations | 48.82%-23.28M | 38.39%-21.1M | 13.59%-186.26M | 3.64%-44.96M | -62.69%-61.58M | 33.83%-45.48M | 45.06%-34.24M | 29.83%-215.56M | 56.81%-46.66M | 68.57%-37.85M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -76.59%3.38M | --0 | --0 |
| Depreciation and amortization | -4.76%18.6M | 18.33%22.56M | 16.24%80.44M | 17.63%22.22M | 9.71%19.62M | 16.65%19.53M | 21.58%19.07M | 27.82%69.2M | 22.99%18.89M | 29.81%17.88M |
| Deferred tax | ---- | ---- | -31.00%-21.92M | ---- | ---- | ---- | ---- | 37.90%-16.73M | ---- | ---- |
| Other non cash items | -11.01%10.5M | -16.76%8.05M | 7.57%45.2M | -69.05%12.72M | 2,665.97%11.01M | 1,764.30%11.8M | 1,226.47%9.67M | 213.39%42.02M | 2,741.15%41.08M | -132.43%-429K |
| Change In working capital | 170.67%13.69M | -97.83%-51.94M | -99.10%-33.72M | 571.68%27.82M | -82.18%-15.93M | -1,035.11%-19.37M | -146.92%-26.25M | -891.50%-16.94M | -86.79%4.14M | 70.41%-8.74M |
| -Change in receivables | 354.88%8.72M | -194.85%-50.53M | -11.60%-24.18M | 87.82%24.31M | -119.79%-27.93M | 9.50%-3.42M | 5.42%-17.14M | 10.53%-21.66M | 469.59%12.94M | -43.09%-12.71M |
| -Change in prepaid assets | 50.60%-5.25M | 154.83%2.49M | 10.52%-3.07M | 1,968.19%49.22M | -7,968.91%-37.12M | -258.37%-10.63M | 62.35%-4.54M | 88.22%-3.43M | -36.82%2.38M | 97.43%-460K |
| -Change in payables and accrued expense | 687.75%22.7M | 37.22%5.71M | 45.77%31.09M | -2,024.35%-38.26M | 1,308.16%62.3M | 162.08%2.88M | -78.71%4.16M | -61.56%21.33M | -93.61%1.99M | 261.34%4.42M |
| -Change in other current liabilities | -52.25%-12.47M | -9.98%-9.61M | -185.25%-37.56M | 43.39%-7.46M | ---13.18M | ---8.19M | ---8.74M | ---13.17M | ---13.17M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 10,252.07%44.06M | -176.78%-21.84M | -131.98%-16.88M | -53.24%16.8M | -542.50%-25.36M | -105.54%-434K | -338.51%-7.89M | 460.39%52.79M | 17.24%35.92M | 140.33%5.73M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 55.88%-5.11M | 81.47%-5.1M | 56.73%-60.34M | 62.33%-11.41M | 51.68%-9.8M | 69.55%-11.58M | 45.83%-27.55M | 28.14%-139.46M | 61.92%-30.3M | 53.49%-20.27M |
| Net PPE purchase and sale | 55.88%-5.11M | 33.96%-5.1M | 48.87%-40.52M | -9.92%-11.41M | 35.11%-9.8M | 55.23%-11.58M | 72.31%-7.73M | 16.13%-79.26M | 73.15%-10.38M | 37.13%-15.1M |
| Net business purchase and sale | --0 | --0 | 67.08%-19.82M | --0 | --0 | --0 | 13.62%-19.82M | 39.54%-60.21M | 51.30%-19.91M | 73.56%-5.18M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 55.88%-5.11M | 81.47%-5.1M | 56.73%-60.34M | 62.33%-11.41M | 51.68%-9.8M | 69.55%-11.58M | 45.83%-27.55M | 28.14%-139.46M | 61.92%-30.3M | 53.49%-20.27M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -106.14%-1.43M | 50.27%-2.43M | 0.34%47.43M | 143.53%30.84M | -122.57%-1.85M | 80.81%23.33M | -136.19%-4.89M | -84.94%47.26M | 183.49%12.66M | 230.65%8.19M |
| Net issuance payments of debt | -103.00%-732K | -24.74%-731K | -20.52%55.28M | 141.13%32.1M | -106.84%-648K | -9.92%24.41M | -102.98%-586K | 132.72%69.56M | 4,134.55%13.31M | 2,962.24%9.47M |
| Net common stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other financing activities | 35.60%-700K | 60.48%-1.7M | 64.76%-7.86M | -94.47%-1.27M | 6.32%-1.2M | 92.35%-1.09M | 30.17%-4.3M | 4.97%-22.29M | 95.61%-651K | -89.93%-1.28M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -106.14%-1.43M | 50.27%-2.43M | 0.34%47.43M | 143.53%30.84M | -122.57%-1.85M | 80.81%23.33M | -136.19%-4.89M | -84.94%47.26M | 183.49%12.66M | 230.65%8.19M |
| Net cash flow | ||||||||||
| Beginning cash position | -27.59%49.45M | -27.43%78.82M | -26.62%108.62M | -52.84%42.61M | -17.67%79.61M | -40.09%68.29M | -26.62%108.62M | 686.18%148.03M | -57.41%90.34M | -64.99%96.69M |
| Current changes in cash | 231.69%37.52M | 27.16%-29.37M | 24.39%-29.8M | 98.08%36.22M | -482.68%-37M | 165.37%11.31M | -18.47%-40.33M | -130.50%-39.41M | 128.53%18.29M | 90.09%-6.35M |
| End cash Position | 9.25%86.97M | -27.59%49.45M | -27.43%78.82M | -27.43%78.82M | -52.84%42.61M | -17.67%79.61M | -40.09%68.29M | -26.62%108.62M | -26.62%108.62M | -57.41%90.34M |
| Free cash flow | 424.18%38.95M | -72.50%-26.94M | -116.90%-57.4M | -78.93%5.38M | -275.30%-35.15M | 33.37%-12.02M | 36.51%-15.62M | 68.89%-26.47M | 417.51%25.53M | 75.50%-9.37M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data